CDC25A
Reactivité: Humain, Souris, Rat
WB, ELISA, IHC, IF, ICC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Immunohistochemistry (1:50-100) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Ito, Yoshida, Matsuzuka, Matsuura, Nakamura, Nakamine, Kakudo, Kuma, Miyauchi: "Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: correlation with histological subtypes and cell proliferation." dans: International journal of molecular medicine, Vol. 13, Issue 3, pp. 431-5, (2004) (PubMed).
Goloudina, Yamaguchi, Chervyakova, Appella, Fornace, Bulavin: "Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint." dans: Cell cycle (Georgetown, Tex.), Vol. 2, Issue 5, pp. 473-8, (2003) (PubMed).
Nemoto, Vogt, Oguri, Lazo: "Activation of the Raf-1/MEK/Erk kinase pathway by a novel Cdc25 inhibitor in human prostate cancer cells." dans: The Prostate, Vol. 58, Issue 1, pp. 95-102, (2003) (PubMed).
Antigène
CDC25A
(Cell Division Cycle 25 Homolog A (S. Pombe) (CDC25A))